TrueBlue (TBI) Falls Short of Q4 View; Guides Down

February 4, 2009 4:25 PM EST

TrueBlue, Inc (NYSE: TBI) reports Q4 EPS of $0.08 ex-impairment, 2 cents below the analyst estimate of $0.10. Revenue for the quarter was $302 million, versus the consensus of $321.40 million.

Sees Q1 sales between $220M to $230M versus consensus of $281.98 million.
Sees Q1 EPS loss 15c to 20c versus $0.02 consensus.


Related Categories

Earnings
Guidance
Hot List

Stocks Mentioned

TBI 13.16

-0.21 -1.57%
Volume: 249,549
Track TBI


Add Your Comment